ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
1554TiP A randomized phase II study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced or metastatic soft tissue sarcoma
Annals of Oncology
◽
10.1016/j.annonc.2021.08.884
◽
2021
◽
Vol 32
◽
pp. S1127-S1128
Author(s):
T. Kessler
◽
D. Pink
◽
P. Reichardt
◽
E. Palmerini
◽
S. Stacchiotti
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Tumor Targeting
◽
Phase Ii Study
◽
Human Antibody
◽
Efficacy And Safety
◽
Randomized Phase Ii
◽
Previously Treated Patients
◽
Metastatic Soft Tissue Sarcoma
◽
Previously Treated
Download Full-text
Related Documents
Cited By
References
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
Case Medical Research
◽
10.31525/ct1-nct04095208
◽
2019
◽
Author(s):
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Proof Of Concept
◽
Randomized Phase Ii
◽
Metastatic Soft Tissue Sarcoma
Download Full-text
Faculty Opinions recommendation of An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718028323.793480222
◽
2013
◽
Author(s):
Richard Riedel
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase 2
◽
Efficacy And Safety
◽
Open Label
◽
Phase 2 Study
◽
Open Label Phase
◽
Metastatic Soft Tissue Sarcoma
◽
Previously Treated
Download Full-text
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.10037
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 10037-10037
◽
Cited By ~ 1
Author(s):
H. Gelderblom
◽
J. Blay
◽
B. M. Seddon
◽
M. Leahy
◽
I. L. Ray-Coquard
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Bone Sarcoma
◽
First Line
◽
Randomized Phase Ii
◽
Metastatic Soft Tissue Sarcoma
◽
Line Chemotherapy
Download Full-text
1553TiP A phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma
Annals of Oncology
◽
10.1016/j.annonc.2021.08.883
◽
2021
◽
Vol 32
◽
pp. S1127
Author(s):
C. Schliemann
◽
D. Pink
◽
A. Flörcken
◽
M. Ahrens
◽
G. Egerer
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Tumor Targeting
◽
Phase Iii
◽
Human Antibody
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Phase Iii Study
◽
Metastatic Soft Tissue Sarcoma
Download Full-text
Faculty Opinions recommendation of Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.11414966.14309054
◽
2011
◽
Author(s):
Fran Hornicek
◽
Edwin Choy
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Previously Treated
Download Full-text
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
European Journal of Cancer
◽
10.1016/j.ejca.2013.06.010
◽
2013
◽
Vol 49
(15)
◽
pp. 3219-3228
◽
Cited By ~ 56
Author(s):
P. Schöffski
◽
D. Adkins
◽
J.-Y. Blay
◽
T. Gil
◽
A.D. Elias
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase 2
◽
Efficacy And Safety
◽
Open Label
◽
Phase 2 Study
◽
Open Label Phase
◽
Metastatic Soft Tissue Sarcoma
◽
Previously Treated
Download Full-text
Faculty Opinions recommendation of Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.11414966.12436065
◽
2011
◽
Author(s):
Florence Duffaud
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Previously Treated
Download Full-text
Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.10594
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 10594-10594
◽
Cited By ~ 2
Author(s):
Xavier Garcia del Muro
◽
Antonio Lopez-Pousa
◽
Javier Martinez-Trufero
◽
Javier Martin Broto
◽
Ricardo Cubedo
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Soft Tissue Sarcoma
◽
Previously Treated Patients
◽
Previously Treated
Download Full-text
Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
Targeted Oncology
◽
10.1007/s11523-017-0539-9
◽
2017
◽
Vol 13
(1)
◽
pp. 81-87
◽
Cited By ~ 5
Author(s):
Juan Martin-Liberal
◽
Antonio López-Pousa
◽
Javier Martínez-Trufero
◽
Javier Martín-Broto
◽
Ricardo Cubedo
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Soft Tissue Sarcoma
◽
Previously Treated Patients
◽
Previously Treated
Download Full-text
1652P A prospective, single-arm phase II study of pegylated-liposome doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma
Annals of Oncology
◽
10.1016/j.annonc.2020.08.1878
◽
2020
◽
Vol 31
◽
pp. S986
Author(s):
X. Liu
◽
X. Zhang
◽
J. Cao
◽
H. Wang
◽
X. Wu
◽
...
Keyword(s):
Soft Tissue
◽
Soft Tissue Sarcoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
First Line
◽
Pegylated Liposome
◽
Metastatic Soft Tissue Sarcoma
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close